Durable responses seen with Amgen's KRAS-blocking cancer drug - STAT

Durable responses seen with Amgen's KRAS-blocking cancer drug - STAT

More reads

• If donating a kidney to a stranger is ethical and allowable, so should taking part in a Covid-19 challenge trial. (STAT)
• Amgen’s KRAS-blocking cancer drug shows durable responses, with tempered expectations. (STAT)
• Agenus sees light at the end of the tunnel at last. (Evaluate)